vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and SPIRE INC (SR). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $762.2M, roughly 1.2× SPIRE INC). SPIRE INC runs the higher net margin — 12.5% vs 0.7%, a 11.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 13.9%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-121.8M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -17.8%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Spire Inc. is a regional public utility holding company based in St. Louis, Missouri, providing natural gas service through its regulated core utility operations while engaging in non-regulated activities that provide business opportunities. Its primary subsidiary Laclede Gas Company is the largest natural gas distribution utility in Missouri, serving approximately 631,000 residential, commercial and industrial customers in the City of St. Louis and ten counties in eastern Missouri. Its corpo...

ASTH vs SR — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.2× larger
ASTH
$950.5M
$762.2M
SR
Growing faster (revenue YoY)
ASTH
ASTH
+29.0% gap
ASTH
42.9%
13.9%
SR
Higher net margin
SR
SR
11.8% more per $
SR
12.5%
0.7%
ASTH
More free cash flow
ASTH
ASTH
$115.8M more FCF
ASTH
$-6.0M
$-121.8M
SR
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
-17.8%
SR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
SR
SR
Revenue
$950.5M
$762.2M
Net Profit
$6.6M
$95.0M
Gross Margin
55.1%
Operating Margin
1.9%
22.8%
Net Margin
0.7%
12.5%
Revenue YoY
42.9%
13.9%
Net Profit YoY
184.4%
16.9%
EPS (diluted)
$0.12
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
SR
SR
Q4 25
$950.5M
$762.2M
Q3 25
$956.0M
$334.1M
Q2 25
$654.8M
$421.9M
Q1 25
$620.4M
$1.1B
Q4 24
$665.2M
$669.1M
Q3 24
$478.7M
$293.8M
Q2 24
$486.3M
$414.1M
Q1 24
$404.4M
$1.1B
Net Profit
ASTH
ASTH
SR
SR
Q4 25
$6.6M
$95.0M
Q3 25
$373.0K
$-39.8M
Q2 25
$9.4M
$20.9M
Q1 25
$6.7M
$209.3M
Q4 24
$-7.8M
$81.3M
Q3 24
$16.1M
$-25.9M
Q2 24
$19.2M
$-12.6M
Q1 24
$14.8M
$204.3M
Gross Margin
ASTH
ASTH
SR
SR
Q4 25
55.1%
Q3 25
Q2 25
Q1 25
Q4 24
55.6%
Q3 24
Q2 24
Q1 24
Operating Margin
ASTH
ASTH
SR
SR
Q4 25
1.9%
22.8%
Q3 25
2.0%
-0.1%
Q2 25
3.1%
16.4%
Q1 25
3.3%
29.1%
Q4 24
0.1%
22.2%
Q3 24
5.9%
6.7%
Q2 24
6.2%
7.4%
Q1 24
7.5%
26.5%
Net Margin
ASTH
ASTH
SR
SR
Q4 25
0.7%
12.5%
Q3 25
0.0%
-11.9%
Q2 25
1.4%
5.0%
Q1 25
1.1%
19.9%
Q4 24
-1.2%
12.2%
Q3 24
3.4%
-8.8%
Q2 24
3.9%
-3.0%
Q1 24
3.7%
18.1%
EPS (diluted)
ASTH
ASTH
SR
SR
Q4 25
$0.12
$1.54
Q3 25
$0.01
$-0.77
Q2 25
$0.19
$0.29
Q1 25
$0.14
$3.51
Q4 24
$-0.14
$1.34
Q3 24
$0.33
$-0.63
Q2 24
$0.40
$-0.28
Q1 24
$0.31
$3.58

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
SR
SR
Cash + ST InvestmentsLiquidity on hand
$429.5M
$4.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$3.4B
Total Assets
$2.2B
$11.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
SR
SR
Q4 25
$429.5M
$4.1M
Q3 25
$463.4M
$5.7M
Q2 25
$342.1M
$13.1M
Q1 25
$260.9M
$15.2M
Q4 24
$290.8M
$11.5M
Q3 24
$350.3M
$4.5M
Q2 24
$327.7M
$7.4M
Q1 24
$337.3M
$25.6M
Stockholders' Equity
ASTH
ASTH
SR
SR
Q4 25
$779.3M
$3.4B
Q3 25
$775.5M
$3.4B
Q2 25
$765.5M
$3.5B
Q1 25
$745.4M
$3.5B
Q4 24
$712.7M
$3.3B
Q3 24
$704.6M
$3.2B
Q2 24
$678.9M
$3.3B
Q1 24
$653.5M
$3.4B
Total Assets
ASTH
ASTH
SR
SR
Q4 25
$2.2B
$11.9B
Q3 25
$2.2B
$11.6B
Q2 25
$1.4B
$11.4B
Q1 25
$1.3B
$11.3B
Q4 24
$1.4B
$11.3B
Q3 24
$1.3B
$10.9B
Q2 24
$1.3B
$10.7B
Q1 24
$1.2B
$10.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
SR
SR
Operating Cash FlowLast quarter
$-2.9M
$81.0M
Free Cash FlowOCF − Capex
$-6.0M
$-121.8M
FCF MarginFCF / Revenue
-0.6%
-16.0%
Capex IntensityCapex / Revenue
0.3%
26.6%
Cash ConversionOCF / Net Profit
-0.44×
0.85×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$-286.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
SR
SR
Q4 25
$-2.9M
$81.0M
Q3 25
$10.0M
$-4.9M
Q2 25
$90.9M
$129.1M
Q1 25
$16.6M
$372.7M
Q4 24
$-10.9M
$81.1M
Q3 24
$34.0M
$82.9M
Q2 24
$23.2M
$270.1M
Q1 24
$6.0M
$489.4M
Free Cash Flow
ASTH
ASTH
SR
SR
Q4 25
$-6.0M
$-121.8M
Q3 25
$7.4M
$-227.6M
Q2 25
$89.5M
$-91.4M
Q1 25
$13.6M
$154.1M
Q4 24
$-13.5M
$-179.5M
Q3 24
$31.7M
$-146.9M
Q2 24
$20.4M
$47.9M
Q1 24
$5.6M
$306.6M
FCF Margin
ASTH
ASTH
SR
SR
Q4 25
-0.6%
-16.0%
Q3 25
0.8%
-68.1%
Q2 25
13.7%
-21.7%
Q1 25
2.2%
14.7%
Q4 24
-2.0%
-26.8%
Q3 24
6.6%
-50.0%
Q2 24
4.2%
11.6%
Q1 24
1.4%
27.2%
Capex Intensity
ASTH
ASTH
SR
SR
Q4 25
0.3%
26.6%
Q3 25
0.3%
66.7%
Q2 25
0.2%
52.3%
Q1 25
0.5%
20.8%
Q4 24
0.4%
38.9%
Q3 24
0.5%
78.2%
Q2 24
0.6%
53.7%
Q1 24
0.1%
16.2%
Cash Conversion
ASTH
ASTH
SR
SR
Q4 25
-0.44×
0.85×
Q3 25
26.69×
Q2 25
9.65×
6.18×
Q1 25
2.48×
1.78×
Q4 24
1.00×
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×
2.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

SR
SR

Residential$474.9M62%
Commercial And Industrial$148.4M19%
Gas Marketing$41.1M5%
Midstream$39.0M5%
Transportation$37.1M5%
Offsystem And Other Inventive$19.7M3%
Other Customer Revenue$4.6M1%

Related Comparisons